Sanofi GMP Problems Require Top-level Sit-down With FDA, But Product Impact Limited So Far
Executive Summary
Agency’s warning letter also includes an uncommon request for a “global assessment” of operations. FDA says sterility of TheraCys lots manufactured since 2000 cannot be assured; company has halted manufacture of the bladder cancer drug and set limits on orders of its Pentacel vaccine.